NeuroPace, Inc. (NPCE)
14.34
-0.15
(-1.04%)
USD |
NASDAQ |
Feb 20, 16:00
14.33
-0.01
(-0.07%)
After-Hours: 20:00
NeuroPace EPS Diluted (Quarterly) : -0.1055 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Standard BioTools, Inc. | -0.0906 |
| Ludwig Enterprises, Inc. | 0.00 |
| QHSLab, Inc. | 0.0017 |
| OpGen, Inc. | -0.0604 |
| Zomedica Corp. | -0.0062 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.496M |
| Revenue (Quarterly) | 27.35M |
| Total Expenses (Quarterly) | 30.85M |
| Enterprise Value | 488.80M |
| Gross Profit Margin (Quarterly) | 77.39% |
| Profit Margin (Quarterly) | -12.78% |
| Earnings Yield | -5.25% |
| Normalized Earnings Yield | -5.168 |